Post-Operative Trigeminal Pain After Microvascular Decompression for Trigeminal Neuralgia

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRutgers, The State University of New Jersey

About this trial

The goal of this observational study is to learn about the long-term effects of microvascular decompression (MVD) in patients with trigeminal neuralgia (TN). The main question it aims to answer is:

Does undergoing post-operative dental treatment or other orofacial stimulation increase the likelihood of pain relapse after MVD for TN?

Participants who have previously undergone MVD for TN as part of their standard medical care will be asked to complete surveys over phone call. These surveys will focus on their pain experiences, timing, anxiety attacks and nature of any pain relapses, and whether they have received dental treatments or other orofacial interventions during follow-up.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

MVD post-operative patients with type I Trigeminal Neuralgia.

Disqualifiers

Atypical (Type II) Facial Pain at presentation, revision surgery.

Patients who are unable or unwilling to provide informed consent will be excluded from the study.

Trial population

Potential participants will be identified through a review of the post-operative patient database at Robert Wood Johnson University Hospital in New Brunswick, New Jersey. Eligible subjects are individuals who have undergone initial microvascular decompression (MVD) surgery for trigeminal neuralgia. Medical records will be accessed through the EPIC system, with IRB approval in place

Trial design

Design model

Other

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Pain control following microvascular decompression (MVD)

Pain control will be assessed using the Barrow Neurological Institute (BNI) Pain Scale to evaluate changes in pain severity and relief after MVD.

Time frame
Up to 60 months post-surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: